Patients’ Global Impression of Change in the management of peripheral neuropathic pain: Clinical relevance and correlations in daily practice.

Eur J Pain. 2019 Jul;23(6):1117-1128. doi: 10.1002/ejp.1378. Epub 2019 Mar 18. Perrot S1, Lantéri-Minet M2,3. Abstract BACKGROUND: Patient-Reported Outcome (PRO) instruments have been developed to evaluate pain management in daily practice; the Patients’ Global Impression of Change (PGIC) is particularly

QAPSA: post-marketing surveillance of capsaicin 8% patch for long-term use in patients with peripheral neuropathic pain in France.

Curr Med Res Opin. 2019 Mar;35(3):417-426. doi: 10.1080/03007995.2018.1558850. Epub 2019 Jan 7. Lantéri-Minet M1,2, Perrot S3. Abstract OBJECTIVE: To describe the characteristics of patients treated with the capsaicin 8% patch, prescribing conditions, long-term effects of repeat treatment on pain intensity

Effects of systemic inhibitors of Acid-Sensing Ion Channels 1 (ASIC1) against acute and chronic mechanical allodynia in a rodent model of migraine.

Br J Pharmacol. 2018 Nov;175(21):4154-4166. doi: 10.1111/bph.14462. Epub 2018 Sep 22. Verkest C1,2,3, Piquet E3,4, Diochot S1,2,3, Dauvois M1, Lanteri-Minet M3,4,5, Lingueglia E1,2,3, Baron A1,2,3. Abstract BACKGROUND AND PURPOSE: Acid-sensing ion channels (ASICs) are neuronal proton sensors emerging as potential

Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study.

Lancet. 2018 Nov 24;392(10161):2280-2287. doi: 10.1016/S0140-6736(18)32534-0. Epub 2018 Oct 22. Reuter U1, Goadsby PJ2, Lanteri-Minet M3, Wen S4, Hours-Zesiger P5, Ferrari MD6, Klatt J5. Abstract BACKGROUND: A substantial proportion of patients with migraine does not respond to, or cannot tolerate,

My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed.

J Headache Pain. 2018 Nov 27;19(1):115. doi: 10.1186/s10194-018-0946-z. Martelletti P1,2, Schwedt TJ3, Lanteri-Minet M4, Quintana R5, Carboni V6, Diener HC7, Ruiz de la Torre E8, Craven A9, Rasmussen AV10, Evans S11, Laflamme AK12, Fink R12, Walsh D13, Dumas P14, Vo

Efficacy and safety of a T-type calcium channel blocker in patients with neuropathic pain: A proof-of-concept, randomized, double-blind and controlled trial.

Eur J Pain. 2018 Aug;22(7):1321-1330. doi: 10.1002/ejp.1221. Epub 2018 Apr 18. Kerckhove N1,2, Pereira B1, Soriot-Thomas S3, Alchaar H4, Deleens R5, Hieng VS6, Serra E3, Lanteri-Minet M1,4, Arcagni P7, Picard P1, Lefebvre-Kuntz D8, Maindet C9, Mick G10, Balp L11, Lucas

Dural and pial pain-sensitive structures in humans: new inputs from awake craniotomies.

Brain. 2018 Jan 29. doi: 10.1093/brain/awy005. [Epub ahead of print] Fontaine D1,2, Almairac F1, Santucci S1,2, Fernandez C1, Dallel R3, Pallud J4,5,6, Lanteri-Minet M2,3,7.  Abstract Our knowledge on intracranial pain-sensitive structures in humans comes essentially from observations during neurosurgical procedures